Vaccination During Pregnancy: Current and Possible Future Recommendations

Overview

Journal Eur J Pediatr

Specialty Pediatrics

Date 2020 Jan 9

PMID 31912233

Citations 28

Authors

Kirsten Maertens

Marjolein Rozemarie Paulien Orije

Pierre Van Damme

Elke Leuridan

Affiliations

Soon will be listed here.

Abstract

Immunizing pregnant women to protect the mother, fetus and infant from infection has increasingly been used over the last decade. Protection against infectious diseases in neonates is mainly provided by maternal antibodies transferred from mother to infant during pregnancy through transplacental transport or after delivery via breastfeeding. Both the transplacental- and breast milk-derived maternal antibodies function as the primary source of protection against infectious diseases in neonates during the first vulnerable weeks of life. During recent infectious disease outbreaks (influenza, pertussis, Zika…) and for other infectious diseases (CMV, GBS…), pregnant women are increasingly identified as an important target for vaccination. For some of these diseases, vaccines are already on the market, and recommended during pregnancy. For others, vaccines are currently under development; furthermore, some are even specifically designed to be administered during pregnancy.Conclusion: This review article provides an overview on the rationale and main mechanism of the maternal vaccination strategy and gives a summary about the current and possible future recommendations for maternal vaccination.What is Known:• Maternal vaccination has a far-reaching potential in the protection of both women and offspring.• Currently, tetanus, pertussis and influenza vaccination during pregnancy is recommended in some countries. Several new vaccines specifically designed for use in pregnancy are currently under development.What is New:• Review providing a timely overview of the rationale and main mechanisms of the maternal vaccination strategy• Up-to-date summary of the current and possible future recommendations for maternal vaccination.

Citing Articles

Research Priorities for Maternal Immunization.

Englund J, Kachikis A Pediatr Infect Dis J. 2025; 44(2S):S13-S15.

PMID: 39951066 PMC: 11839155. DOI: 10.1097/INF.0000000000004587.

Attitudes towards Maternal Immunisation of Polish Mothers: A Cross-Sectional, Non-Representative Study.

Kiersnowska I, Kalita-Kurzynska K, Piekutowska-Kowal W, Baranowska J, Krzych-Falta E Vaccines (Basel). 2024; 12(10).

PMID: 39460310 PMC: 11511576. DOI: 10.3390/vaccines12101143.

Acceptance and uptake of vaccines against tetanus, influenza, pertussis, and COVID-19 among pregnant and postpartum women in low- and middle-income countries: a systematic review and meta-analysis protocol.

Ayouni I, Mbangiwa T, Amponsah-Dacosta E, Noll S, Kagina B, Muloiwa R Syst Rev. 2024; 13(1):227.

PMID: 39237969 PMC: 11375862. DOI: 10.1186/s13643-024-02645-7.

Pregnant individuals perspectives towards receiving COVID-19 vaccination during their pregnancy: an in-depth qualitative study.

Zilver S, Rietveld A, Schonewille N, Bakker P, Broekman B, van Leeuwen E Front Public Health. 2024; 12:1415548.

PMID: 39234090 PMC: 11371620. DOI: 10.3389/fpubh.2024.1415548.

The Multi-faceted Effects of COVID-19 on Female Reproductive Health: An Updated Narrative Review.

Al-Bdairi A, Makki H, Shawki O, Alkhudair S, Al-Hilli N, Alkhalidi B Cureus. 2024; 16(4):e57944.

PMID: 38738039 PMC: 11082527. DOI: 10.7759/cureus.57944.

References

Maertens K, Cabore R, Huygen K, Hens N, Van Damme P, Leuridan E . Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study. Vaccine. 2015; 34(1):142-50. DOI: 10.1016/j.vaccine.2015.10.100. View

Maertens K, De Schutter S, Braeckman T, Baerts L, Van Damme P, De Meester I . Breastfeeding after maternal immunisation during pregnancy: providing immunological protection to the newborn: a review. Vaccine. 2014; 32(16):1786-92. DOI: 10.1016/j.vaccine.2014.01.083. View

Calvert A, Jones C . Placental transfer of antibody and its relationship to vaccination in pregnancy. Curr Opin Infect Dis. 2017; 30(3):268-273. DOI: 10.1097/QCO.0000000000000372. View

Faucette A, Unger B, Gonik B, Chen K . Maternal vaccination: moving the science forward. Hum Reprod Update. 2014; 21(1):119-35. PMC: 4255605. DOI: 10.1093/humupd/dmu041. View

Palmeira P, Quinello C, Silveira-Lessa A, Zago C, Carneiro-Sampaio M . IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012; 2012:985646. PMC: 3251916. DOI: 10.1155/2012/985646. View

Abu-Raya B, Smolen K, Willems F, Kollmann T, Marchant A . Transfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected Newborns. Front Immunol. 2016; 7:338. PMC: 5005931. DOI: 10.3389/fimmu.2016.00338. View

De Schutter S, Maertens K, Baerts L, De Meester I, Van Damme P, Leuridan E . Quantification of vaccine-induced antipertussis toxin secretory IgA antibodies in breast milk: comparison of different vaccination strategies in women. Pediatr Infect Dis J. 2015; 34(6):e149-52. DOI: 10.1097/INF.0000000000000675. View

Abu Raya B, Srugo I, Kessel A, Peterman M, Bader D, Peri R . The induction of breast milk pertussis specific antibodies following gestational tetanus-diphtheria-acellular pertussis vaccination. Vaccine. 2014; 32(43):5632-7. DOI: 10.1016/j.vaccine.2014.08.006. View

Malek A, Sager R, Schneider H . Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy. Am J Reprod Immunol. 1994; 32(1):8-14. DOI: 10.1111/j.1600-0897.1994.tb00873.x. View

10.

Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P . Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ. 2010; 340:c1626. DOI: 10.1136/bmj.c1626. View

11.

Hoang H, Leuridan E, Maertens K, Nguyen T, Hens N, Vu N . Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy. Vaccine. 2015; 34(1):151-9. DOI: 10.1016/j.vaccine.2015.10.098. View

12.

Voysey M, Pollard A, Sadarangani M, Fanshawe T . Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates. Vaccine. 2017; 35(43):5850-5857. PMC: 5628610. DOI: 10.1016/j.vaccine.2017.09.002. View

13.

Vilajeliu A, Ferrer L, Munros J, Gonce A, Lopez M, Costa J . Pertussis vaccination during pregnancy: Antibody persistence in infants. Vaccine. 2016; 34(33):3719-22. DOI: 10.1016/j.vaccine.2016.05.051. View

14.

Marchant A, Sadarangani M, Garand M, Dauby N, Verhasselt V, Pereira L . Maternal immunisation: collaborating with mother nature. Lancet Infect Dis. 2017; 17(7):e197-e208. DOI: 10.1016/S1473-3099(17)30229-3. View

15.

Orije M, Maertens K, Corbiere V, Wanlapakorn N, Van Damme P, Leuridan E . The effect of maternal antibodies on the cellular immune response after infant vaccination: A review. Vaccine. 2019; 38(1):20-28. DOI: 10.1016/j.vaccine.2019.10.025. View

16.

Niewiesk S . Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol. 2014; 5:446. PMC: 4165321. DOI: 10.3389/fimmu.2014.00446. View

17.

Thwaites C, Beeching N, Newton C . Maternal and neonatal tetanus. Lancet. 2014; 385(9965):362-70. PMC: 5496662. DOI: 10.1016/S0140-6736(14)60236-1. View

18.

STANFIELD J, Galazka A . Neonatal tetanus in the world today. Bull World Health Organ. 1984; 62(4):647-69. PMC: 2536335. View

19.

Liang J, Tiwari T, Moro P, Messonnier N, Reingold A, Sawyer M . Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018; 67(2):1-44. PMC: 5919600. DOI: 10.15585/mmwr.rr6702a1. View

20.

Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S . Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol. 2010; 39 Suppl 1:i102-9. PMC: 2845866. DOI: 10.1093/ije/dyq027. View